Ronald Hunt Iterum Therapeutics PLC (ITRM) insider trading activity

ITRM Quotes by TradingView

Ronald Hunt is Director of Iterum Therapeutics plc. Currently has a direct ownership of 14,346 shares of ITRM, which is worth approximately $16,497. The most recent transaction as insider was on Oct 01, 2023, when has been sold 5,479 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
0% 3M change
136.3% 12M change
Total Value Held $16,497

RONALD HUNT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2023
BUY
Exercise of conversion of derivative security
-
5,479 Added 27.64%
14,346 Ordinary Shares
Jul 01 2023
BUY
Exercise of conversion of derivative security
-
2,796 Added 23.97%
8,867 Ordinary Shares
Apr 01 2023
BUY
Exercise of conversion of derivative security
-
2,041 Added 25.16%
6,071 Ordinary Shares
Jan 01 2023
BUY
Exercise of conversion of derivative security
-
1,197 Added 22.9%
4,030 Ordinary Shares
Jun 23 2022
BUY
Exercise of conversion of derivative security
-
36,798 Added 46.4%
42,501 Ordinary Shares

Also insider at

HARP
Harpoon Therapeutics, Inc. Healthcare
RLYB
Rallybio Corp Healthcare
Director
RH

Ronald Hunt

Director
Dublin 2, L2

Track Institutional and Insider Activities on ITRM

Follow Iterum Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITRM shares.

Notify only if

Insider Trading

Get notified when an Iterum Therapeutics PLC insider buys or sells ITRM shares.

Notify only if

News

Receive news related to Iterum Therapeutics plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITRM